- Home
- DNTH vs MBUU Comparison
DNTH vs MBUU Comparison
Compare DNTH & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- MBUU
- Stock Information
- Founded
- DNTH 2015
- MBUU 1982
- Country
- DNTH United States
- MBUU United States
- Employees
- DNTH N/A
- MBUU N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- MBUU Marine Transportation
- Sector
- DNTH Health Care
- MBUU Industrials
- Exchange
- DNTH Nasdaq
- MBUU Nasdaq
- Market Cap
- DNTH 823.1M
- MBUU 812.7M
- IPO Year
- DNTH N/A
- MBUU 2014
- Fundamental
- Price
- DNTH $20.27
- MBUU $42.06
- Analyst Decision
- DNTH Strong Buy
- MBUU Buy
- Analyst Count
- DNTH 8
- MBUU 7
- Target Price
- DNTH $46.43
- MBUU $44.33
- AVG Volume (30 Days)
- DNTH 291.2K
- MBUU 215.1K
- Earning Date
- DNTH 11-07-2024
- MBUU 10-31-2024
- Dividend Yield
- DNTH N/A
- MBUU N/A
- EPS Growth
- DNTH N/A
- MBUU N/A
- EPS
- DNTH N/A
- MBUU N/A
- Revenue
- DNTH $5,366,000.00
- MBUU $744,785,000.00
- Revenue This Year
- DNTH $44.94
- MBUU $4.07
- Revenue Next Year
- DNTH N/A
- MBUU $10.12
- P/E Ratio
- DNTH N/A
- MBUU N/A
- Revenue Growth
- DNTH 51.41
- MBUU N/A
- 52 Week Low
- DNTH $6.58
- MBUU $30.20
- 52 Week High
- DNTH $33.77
- MBUU $56.03
- Technical
- Relative Strength Index (RSI)
- DNTH 22.81
- MBUU 51.79
- Support Level
- DNTH $22.19
- MBUU $39.60
- Resistance Level
- DNTH $28.56
- MBUU $41.81
- Average True Range (ATR)
- DNTH 2.02
- MBUU 1.51
- MACD
- DNTH -0.88
- MBUU -0.37
- Stochastic Oscillator
- DNTH 3.38
- MBUU 31.95
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About MBUU Malibu Boats Inc.
Malibu Boats is a leading designer and manufacturer of power boats in the United States. It is the market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a leading producer of sterndrive boats in the us in the 24- to 29-foot segment, in 2017 and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a leading seller of flat fishing boats, including bay, dual-console, and center-console boats. Malibu has also expanded into boat trailers and accessories and in 2020 began producing its own engines (Monsoon) for its performance sport boats and now for Cobalt. Malibu's target market includes a wide range of water enthusiasts who embrace the active outdoor lifestyle.